Wird geladen...
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?
The use of biological agents and immunomodulators for inflammatory bowel disease (IBD) is associated with an increased risk of opportunistic infections, in particular of viral or bacterial etiology. Despite the existence of international guidelines, many gastroenterologists have not adopted routine...
Gespeichert in:
| Veröffentlicht in: | World J Gastrointest Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986392/ https://ncbi.nlm.nih.gov/pubmed/27602239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v7.i3.387 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|